Skip to main content
. 2016 Aug;6(8):a028324. doi: 10.1101/cshperspect.a028324

Figure 2.

Figure 2.

Antifolates. Clinically approved antibacterial antifolates: trimethoprim and sulfamethoxazole. Preclinical and experimental antifolates: dihydrofolate reductase (DHFR) inhibitors iclaprim and propargyl-linked antifolates, and dihydropteroate synthase pyridazine (DHPS) inhibitors.